The Boss medical devices have gone from being a symbol of innovation to a symbol for cheap labor, according to a report from Axios.

The company, which manufactures devices to treat chronic pain, arthritis, and cancer, recently announced it will be exiting the U.S. market and closing its medical devices business, including the Rongeur, Boss, and Proterra models.

The company, whose main product is the Rondeur, was founded in 2015 by cofounder Mark Rongeu, a former employee of GE.

The Boss has been around for decades, but was acquired by Japanese industrial giant Sumitomo in 2017.

The company has made no public announcement on when it plans to reopen its medical products business.

It is unclear whether the company will continue to sell the Rondes and Bosses that were built with labor in mind or simply focus on new products that could be made with a higher quality and design.